Betsy Vasquez serves as the Senior Director of Regulatory Affairs at Carmot Therapeutics, Inc., where she plays a pivotal role in shaping the regulatory strategy for innovative therapies, particularly in the realm of GIP/GLP-1 receptor agonists. With over 25 years of extensive experience in both...
Betsy Vasquez serves as the Senior Director of Regulatory Affairs at Carmot Therapeutics, Inc., where she plays a pivotal role in shaping the regulatory strategy for innovative therapies, particularly in the realm of GIP/GLP-1 receptor agonists. With over 25 years of extensive experience in both industry and consulting, Betsy has developed a robust expertise in navigating the complex landscape of global regulatory compliance, from the early stages of drug discovery through to clinical development and commercialization. Her leadership is instrumental in guiding cross-functional teams, including clinical, safety, nonclinical, and chemistry, manufacturing, and controls (CMC), ensuring that all aspects of product development align with regulatory requirements.
At Carmot Therapeutics, a member of the Roche Group, Betsy is currently focused on advancing therapies indicated for chronic weight management in patients with obesity and related comorbidities, as well as addressing the needs of individuals with Type 1 and Type 2 diabetes. Her strategic oversight encompasses the development of regulatory submissions to the U.S. Food and Drug Administration (FDA) and other global health authorities, where her insights into regulatory labeling and advertising are crucial for successful product positioning in the market.
Betsy’s diverse background in global regulatory affairs equips her with a unique perspective on the intersection of science and regulation, allowing her to effectively advocate for innovative solutions that meet patient needs while ensuring compliance with stringent regulatory standards. Her commitment to fostering collaboration across teams and her deep understanding of the regulatory landscape make her a key asset in driving Carmot Therapeutics' mission to deliver transformative therapies to patients worldwide.
